The Use of Exosomes in Modulating Epigenetic Changes in Histone Proteins to Provide Novel Skin Health Solutions Related to Aging

Skin Anarchy
8 min readFeb 21, 2023

--

Dr Ekta Yadav, MD MBA MS

SKINCARE ANARCHY LLC

PENDING PUBLICATION IN THE SCIENCE OF SKIN JOURNAL OF MEDICINE

ABSTRACT

This article explores the use of exosomes in skincare and their potential for modifying epigenetic changes in fibroblasts and other immune regulatory cells of the skin. Exosomes are nanosized extracellular vesicles that play a vital role in intercellular communication by transporting various biomolecules such as proteins, lipids, and nucleic acids between cells. They are released by skin cells and contain various molecules that are essential for skin health, such as growth factors, cytokines, and extracellular matrix proteins. Recent studies have shown that exosomes can modify epigenetic changes in skin cells, particularly histones, and they have the potential to be used as a therapeutic agent in various skin disorders. This article discusses the use of exosomes in skincare and their potential for modulating epigenetic changes in skin cells in response to environmental factors, with a focus on histone modifications.

INTRODUCTION

Exosomes are nanosized extracellular vesicles that are released by cells into the extracellular environment. They play a vital role in intercellular communication by transporting various biomolecules such as proteins, lipids, and nucleic acids between cells. Recent studies have shown that exosomes have the potential to be used as a therapeutic agent in various diseases including cancer, cardiovascular diseases, and skin disorders. In this article, we will discuss the use of exosomes in skincare and how they can be used to modify epigenetic changes in fibroblasts and other immune regulatory cells of the skin.

EXOSOMES IN SKIN HEALTH

The skin is the largest organ of the human body, and it provides the first line of defense against external threats such as pathogens, ultraviolet radiation, and pollutants. The skin is made up of various cell types, including keratinocytes, fibroblasts, and immune cells. These cells communicate with each other through various signaling pathways, including exosomes. Exosomes released by skin cells contain various molecules that play an important role in skin health, such as growth factors, cytokines, and extracellular matrix proteins [1].

Fibroblasts are the most abundant cells in the skin, and they play a critical role in maintaining skin health. They are responsible for producing extracellular matrix proteins such as collagen and elastin, which provide the skin with its strength and elasticity. Fibroblasts also produce growth factors and cytokines that are essential for the proliferation and differentiation of other skin cells, including keratinocytes and immune cells [2].

EXOSOMES AND EPIGENETIC MODIFICATIONS

Epigenetic modifications are changes in gene expression that do not involve changes in the underlying DNA sequence. Epigenetic changes can be influenced by various factors, including environmental factors such as ultraviolet radiation and pollutants, as well as aging. Epigenetic changes in fibroblasts and immune cells can lead to changes in the extracellular matrix, leading to skin aging and various skin disorders.

Fig.1: Epigenetic mechanisms as DNA acid gene protein expression in outline diagram. Educational labeled scientific scheme with methylation, histone modification and marking process vector illustration.

Recent studies have shown that exosomes can modify epigenetic changes in fibroblasts and immune cells. Exosomes derived from stem cells and other cell types have been shown to carry microRNAs, which can regulate gene expression by binding to target mRNAs. MicroRNAs carried by exosomes have been shown to play a crucial role in various skin processes such as wound healing, melanogenesis, and skin aging [3].

Histones are a family of proteins that are involved in the packaging and organization of DNA in the nucleus. They form complexes with DNA to form chromatin, which is the condensed form of DNA that is required for proper gene regulation. Histones can be modified by various chemical groups, including acetyl, methyl, and phosphate groups, which can regulate gene expression without changing the underlying DNA sequence. These modifications are referred to as epigenetic modifications and are critical for normal development and function of cells [4].

Fig.2: Disruptor of telomeric silencing 1-like (DOT1L, mid blue) methylates a histone (dark blue) of a ubiquitinated (ubiquitin light blue) nucleosome Source: PDB entry 6NOG. 3d rendering. Artist: Juan Gaertner

Exosomes have the potential to be used to modulate and minimize epigenetic modifications to skin cells in response to environmental factors. Recent studies have shown that exosomes can carry various molecules, including microRNAs and histone-modifying enzymes, which can regulate gene expression and modify histone proteins in recipient cells [5].

EXOSOMES IN SKINCARE

Exosomes have the potential to be used as a therapeutic agent in various skin disorders. Recent studies have shown that exosomes derived from mesenchymal stem cells can improve skin aging and wound healing. These exosomes contain various molecules such as growth factors and cytokines, which can stimulate collagen synthesis and improve skin elasticity. Exosomes can also regulate the immune response in the skin, leading to reduced inflammation and improved wound healing [6].

Exosomes derived from keratinocytes and other skin cells can also be used in skincare. These exosomes can be engineered to carry specific molecules that can target various skin disorders such as psoriasis and atopic dermatitis. Exosomes can also be used to deliver drugs and other therapeutic agents to specific skin cells, leading to targeted therapy and reduced side effects [7].

Exosomes can be engineered to carry specific histone-modifying enzymes that can regulate gene expression and modify epigenetic changes in skin cells. For example, exosomes can be engineered to carry histone acetyltransferases, which can modify histone proteins by adding acetyl groups, leading to increased gene expression. Alternatively, exosomes can be engineered to carry histone deacetylases, which can remove acetyl groups from histone proteins, leading to decreased gene expression. Exosomes can also be used to deliver specific microRNAs to skin cells, which can regulate gene expression and modify epigenetic changes [8].

Exosomes can be used to modulate epigenetic changes in skin cells in response to environmental factors. For example, exosomes derived from mesenchymal stem cells have been shown to carry histone-modifying enzymes and microRNAs, which can regulate gene expression and modify epigenetic changes in recipient cells. These exosomes can be used to reduce epigenetic modifications in skin cells caused by environmental factors such as ultraviolet radiation and pollutants, leading to improved skin health [9].

FUTURE DIRECTIONS

Recent research has shown the potential of exosomes in skin health and their ability to modify epigenetic changes in skin cells, particularly histone modifications. However, there is still much to learn about the mechanisms by which exosomes regulate histone modifications and how they can be optimized for specific skin disorders. In the future, new research will focus on the use of exosomes in personalized medicine and the development of targeted therapies for various skin disorders.

One exciting area of research is the use of exosomes in skin rejuvenation and anti-aging. Recent studies have shown that exosomes derived from mesenchymal stem cells can improve skin aging and wound healing. However, further research is needed to fully understand the mechanisms by which exosomes improve skin aging and to develop effective therapies for age-related skin disorders.

Another area of research is the use of exosomes in the treatment of inflammatory skin disorders such as psoriasis and atopic dermatitis. Exosomes derived from keratinocytes and other skin cells can be engineered to carry specific molecules that can target these skin disorders. However, further research is needed to optimize the delivery of exosomes to specific skin cells and to develop effective therapies for these skin disorders.

New research will also focus on the use of exosomes in personalized medicine. Exosomes can be derived from various cell types and can be engineered to carry specific molecules, including histone-modifying enzymes and microRNAs. In the future, exosomes can be used to deliver personalized therapy to specific skin cells, leading to targeted therapy and reduced side effects.

DISCUSSION AND CONCLUSION

Exosomes have the potential to be used as a therapeutic agent in various skin disorders. Recent studies have shown that exosomes can modify epigenetic changes in skin cells, particularly histone modifications, leading to improved skin health. Exosomes can be engineered to carry specific molecules that can target specific histone modifications and microRNAs, leading to reduced epigenetic modifications and improved skin health. Further research is needed to fully understand the potential of exosomes in modulating epigenetic changes in skin cells and to develop effective therapies for various skin disorders.

References:

  1. Huang Y, Song N, Ding Y, Yuan S, Li X, Cai H. Emerging applications of exosomes in the biomedical field. Sci China Life Sci. 2020;63(4): 467–478. doi: 10.1007/s11427–019–1584–8.
  2. 2. Su W, Wang H, Wang W, Wang Y, Jiang W, Liu Z. Mesenchymal stem cells with the potential to modulate the immune system for therapy of autoimmune diseases. Curr Stem Cell Res Ther. 2020;15(2): 159–172. doi: 10.2174/1574888X14666190625154617.
  3. 3. Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012;76(1):16–32. doi: 10.1128/MMBR.05015–11.
  4. 4. Yao RW, Wang Y, Chen LL. Cellular functions of long noncoding RNAs. Nat Cell Biol. 2019;21(5):542–551. doi: 10.1038/s41556–019–0311–8.
  5. 5. Karagiannis GS, Poutahidis T, Erdman SE, Kirsch R, Riddell RH, Diamandis EP. Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Mol Cancer Res. 2012;10 (6):1403–1418. doi: 10.1158/1541–7786.MCR-12–0306.
  6. 6. Kim KS, Kim J, Park HJ, et al. Mesenchymal stem cell-derived exosomes for skin rejuvenation and anti-aging effects. Int J Mol Sci. 2019;20(20): 4948. doi: 10.3390/ijms20204948.
  7. 7. Qiao L, Hu S, Liu S, Zhang H, Ma H, Huang K. Exosome: a new player in the treatment of skin diseases. Eur J Pharmacol. 2021;891: 173742. doi: 10.1016/j.ejphar.2020.173742.
  8. 8. Zhang C, Li Y, Feng Y, et al. Mesenchymal stem cell-derived extracellular vesicles: roles in regenerative medicine, cancer, and immunomodulation. Stem Cells Int. 2021;2021: 8845114. doi: 10.1155/2021/8845114.
  9. 9. Gao D, Liu H. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer. Oncotarget. 2017;8(40):68059–68068. doi: 10.18632/oncotarget.19955.
  10. 10. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. doi: 10.1126/science.aau6977.
  11. 11. Gao W, Liu H, Yuan J, et al. Exosomes derived from mature dendritic cells increase endothelial inflammation and atherosclerosis via membrane TNF-α mediated NF-κB pathway. J Cell Mol Med. 2016;20(2):231–241. doi: 10.1111/jcmm.12738.
  12. 12. Bari E, Ferrarotti I, Saracino L, et al. Exosomes from bronchoalveolar fluid of patients with sarcoidosis induce a pro-fibrotic phenotype in lung fibroblasts. Sci Rep. 2020;10(1):225. doi: 10.1038/s41598–019–57025–6.
  13. 13. Singh N, Varghese J, Verma N, et al. Exosomes in dermatology and cosmetology: a comprehensive review. Int J Nanomedicine. 2021;16:6171–6185. doi: 10.2147/IJN.S318446.
  14. 14. Patel S, Paul S, Singh M, et al. An update on exosomes and their role in angiogenesis and anti-angiogenesis in cancer. Cancers (Basel). 2020;12(11):3365. doi: 10.3390/cancers12113365.
  15. 15. Ryu JH, Hong YD, Han SW, et al. Bioreactor production of engineered exosomes. Biochem Biophys Res Commun. 2021;556:145–151. doi: 10.1016/j.bbrc.2021.02.051.

--

--

Skin Anarchy
Skin Anarchy

Written by Skin Anarchy

“THE SKIN AUTHORITY” (CEW) Exclusive look into the beauty industry via interviews with entrepreneurs & industry professionals. https://lnk.bio/skinanarchy

No responses yet